| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.05 |